Alpha 2.0
Login Register
» Authors » Lisa Cariani

Lisa Cariani

Explore the profile of Lisa Cariani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 798
Followers 0
Related Specialties
Pulmonary Medicine
Microbiology
Science
Top 10 Co-Authors
Carla Colombo
Antonio Teri
Daniela Girelli
Francesco Blasi
Valeria Dacco
Alessandra Bandera
Beatrice Silvia Orena
Andrea Gramegna
Antonio Muscatello
Samantha Sottotetti
Published In
J Cyst Fibros
PLoS One
New Microbiol
Antibiotics (Basel)
Pediatr Pulmonol
Affiliations
Soon will be listed here.
Recent Articles
1.
Dealing With Antibiotic Prophylaxis in Lung Transplantation in the Era of Multidrug Resistance: The Milano Algorithm
Lombardi A, Mangioni D, Renisi G, Fumagalli J, Morlacchi L, Rosso L, et al.
Transplant Proc . 2025 Jan; 57(2):339-341. PMID: 39788793
Infectious complications significantly impact morbidity and mortality following lung transplantation (LuTx), with over 25% of post-transplant deaths attributed to infections. Antibiotic prophylaxis during the surgical procedure is crucial for reducing...
2.
Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection
Lanfranchi C, Alicandro G, Cariani L, Orena B, Gramegna A, Rizza C, et al.
Lung . 2025 Jan; 203(1):24. PMID: 39762638
Purpose: The study evaluated the effects of elexacaftor/tezacaftor/ivacaftor (ETI) therapy in people with cystic fibrosis (pwCF) and a clinical history of Aspergillus fumigatus (AF) infection. Methods: This prospective cohort study...
3.
Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals
Alteri C, Teri A, Liporace M, Muscatello A, Terranova L, Schianca M, et al.
Ann Clin Microbiol Antimicrob . 2024 Nov; 23(1):104. PMID: 39614286
Background: During prolonged FDC therapy, the emergence of FDC non-susceptibility in CRAB has been reported. Here, we report a transmission cluster of FDC-non-susceptible CRAB in four patients, all naïve to...
4.
Active Surveillance of Patients Colonized with CRE: A Single-Center Study Based on a Combined Molecular/Culture Protocol
Orena B, Liporace M, Teri A, Girelli D, Salari F, Mutti M, et al.
Antibiotics (Basel) . 2024 Nov; 13(11). PMID: 39596746
: Carbapenem-resistant (CRE) are types of bacteria that need urgent attention globally. Active surveillance programs at hospitals are essential for the early identification of CRE carriers and the timely adoption...
5.
Genomic characterization of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) strains circulating in three university hospitals in Northern Italy over three years
Fox V, Mangioni D, Renica S, Comelli A, Teri A, Zatelli M, et al.
Antimicrob Resist Infect Control . 2024 Jul; 13(1):70. PMID: 38961463
Objectives: Genomic surveillance of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is crucial for virulence, drug-resistance monitoring, and outbreak containment. Methods: Genomic analysis on 87 KPC-Kp strains isolated from 3 Northern...
6.
Single-Cell RNA Sequencing Shows that Circulating Monocytes Enriched in IFN Signaling Are Associated with Nontuberculous Mycobacteria Pulmonary Disease in Cystic Fibrosis
Lore N, Gramegna A, de Pretis S, Di Marco F, Giannese F, Saliu F, et al.
Am J Respir Crit Care Med . 2024 Jun; 210(6):834-837. PMID: 38889330
No abstract available.
7.
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization
Mangioni D, Fox V, Saltini P, Lombardi A, Bussini L, Carella F, et al.
Front Microbiol . 2024 Jan; 14:1287522. PMID: 38274761
Background: Group A Streptococcus (GAS) causes multiple clinical manifestations, including invasive (iGAS) or even life-threatening (severe-iGAS) infections. After the drop in cases during COVID-19 pandemic, in 2022 a sharp increase...
8.
Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis
Di Bonaventura G, Lupetti V, Di Giulio A, Muzzi M, Piccirilli A, Cariani L, et al.
Microbiol Spectr . 2023 Jun; 11(4):e0035223. PMID: 37306577
Pseudomonas aeruginosa is the most common pathogen infecting cystic fibrosis (CF) lungs, causing acute and chronic infections. Intrinsic and acquired antibiotic resistance allow P. aeruginosa to colonize and persist despite...
9.
Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in...
Mangioni D, Fox V, Chatenoud L, Bolis M, Bottino N, Cariani L, et al.
Microbiol Spectr . 2023 Mar; :e0020923. PMID: 36976013
COVID-19 has significantly affected hospital infection prevention and control (IPC) practices, especially in intensive care units (ICUs). This frequently caused dissemination of multidrug-resistant organisms (MDROs), including carbapenem-resistant Acinetobacter baumannii (CRAB)....
10.
Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment
Dacco V, Alicandro G, Consales A, Rosazza C, Sciarrabba C, Cariani L, et al.
Pediatr Pulmonol . 2023 Feb; 58(5):1337-1343. PMID: 36815622
Background: Cepacia syndrome (CS) is an acute, necrotizing pneumonia with a high mortality rate, occurring in patients with cystic fibrosis (CF) infected with Burkholderia cepacia complex (BCC). Due to its...